Close Menu

NEW YORK – With a pair of rapid assays in hand, Portland, Oregon-based startup Hemex Health will soon launch a malaria test through its subsidiary in India, while it collaborates with Novartis for a sickle cell diagnosis and treatment in Africa.

Cofounded in 2015 by Patti White, now the firm's CEO, and biomedical device developer Peter Galen, Hemex's flagship technology is its point-of-care Gazelle instrument, a portable, battery-operated, cartridge-based diagnostics system with two testing ports.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.